Cited by 64Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAdvanced MRI Techniques and Applications

Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510)

Yang, Dewen, Xie, Zhiyong, Stephenson, Diane, Morton, Daniel, Hicks, Carol D., Brown, Tracy M., Sriram, Renuka, O'Neill, Sharon +2 more·2011·NeuroImage

Abstract

The purpose of this study was to determine if in vivo high resolution 3D MRI and localized (1)H MR spectroscopy (MRS) can detect brain findings resembling Alzheimer's disease in a transgenic mouse model of Tau pathology. Seven double transgenic rTg4510 female mice and 7 age-matched wild-type (wt) female mice were evaluated at 5 months of age. To confirm the usefulness and consistency of in vivo MRI/S, we also scanned the brains of 14 male mice (7 rTg4510 and 7 age-matched wt) at 8 months of age. Mean hippocampal and cerebral cortex volumes in the female rTg4510 mice were 26.7% and 20.6% smaller than that in the wt controls (p<0.0001), respectively. Mean hippocampal and cerebral cortex volumes in the male rTg4510 mice were 18.4% and 16.9% smaller than that in the wt controls (p<0.00005), respectively. The mean volumes of the cerebellum were not statistically different between the rTg4510 and the wt groups. MRS assessment revealed that the myo-inositol to total creatine ratios (mIns/tCr), a measure of gliosis, were significantly higher in the hippocampus of rTg4510 mice relative to wt mice (p=0.03 for the females; p=0.005 for the males). Immunohistochemistry and histology in the same animals verified previously published data showing elevation of hyperphosphorylated Tau, glial activation and cortical and hippocampal neuronal loss. This study demonstrates that in vivo MRI/S can be a non-invasive biomarker to assess brain atrophy and related biochemical changes in the rTg4510 mou…

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2010.10.067

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previously published work has reported structural changes in rTg4510 mice in the hippocampus and cerebral cortex, as well as enlargement of the ventricles using in vivo MRI.

    “Previously published work has reported structural changes in rTg4510 mice in the hippocampus and cerebral cortex, as well as enlargement of the ventricles using in vivo MRI (Yang et al., 2011).”

    From In vivo imaging of tau pathology using multi-parametric quantitative MRI (2015) · cites this paper as Yang et al., 2011

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yang, D., Xie, Z., Stephenson, D., Morton, D., Hicks, C. D., Brown, T. M., Sriram, R., O'Neill, S., Raunig, D., & Bocan, T.
Affiliations
Pfizer (United States) (US)
Corresponding author
Yang, Dewen
Venue
NeuroImage
Publisher
Elsevier BV
Published
2011-02
Volume
54
Issue
4
Pages
2652-2658
ISSN
1053-8119 (ISSN-L)
OpenAlex
W2157899039
Cited by
64
References
4
Citations by year
2024: 1 · 2022: 6 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 12 · 2016: 3 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 8
FWCI
3.90
Type
journal article
Language
en
Open access
closed
Locations
  • NeuroImage (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
Keywords
Alzheimer's disease, rTg4510 mice, tauopathy, 3D MRI, brain atrophy, hippocampal volume, gliosis, hyperphosphorylated tau, glial activation, neuronal loss, in vivo biomarkers, transgenic mouse model
MeSH terms
Alzheimer Disease, Animals, Brain, Disease Models, Animal, Female, Immunohistochemistry, Magnetic Resonance Imaging, Male, Mice, Transgenic, Magnetic Resonance Spectroscopy, tau Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review